Ryan Specialty Holdings, Inc.
NYSE:RYANInsurance - Specialty
-$0.59 today
- Market cap
- $5.79B
- Beta
- 0.64
- P/E (TTM)
- 34.2
- EPS (TTM)
- $1.02
- Dividend yield
- 1.44%
Volume 1.38M
Average 2.89M
RYAN EPS (Diluted)
Earnings per share assuming conversion of dilutive securities such as options and convertible instruments.
Ryan Specialty Holdings, Inc.NYSE: RYAN
EPS (Diluted) · Q2 FY2026 · quarter ended Jun 2026
EPS (Diluted) grows, but more slowly than its trailing trend
Q2 FY2026 EPS (Diluted) of $0.33 rose 73.7% year over year, behind the +559.5% change in trailing-twelve-month EPS (Diluted). Sequentially, it rose 6.5% from the prior quarter. Over 3 fiscal years it compounded at -3.3% a year.
Context
- EPS (Diluted) increased in 1 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether EPS (Diluted) reaches the consensus estimate from 11 analysts of $2.18 (+364.0%) for the fiscal year ending Dec 2026, a step up from the -33.8% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $0.33+6.5% QoQ
- Last fiscal yearDec 2025
- $0.47-33.8% YoY
- LTMJun 2026
- $0.78+559.5% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +73.7% | +341.3% | +267.6 pp |
| 1 year | -33.8% | +364.0% | +397.8 pp |
| 3-year CAGR | -3.3% | +79.0% | +82.3 pp |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
EPS (Diluted) history
USD · from the income statement
- Latest · FY2025
- 0.47 USD
- Year-over-year change
- -33.8%
| Period | Period end | EPS (Diluted) | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0.47 | -33.8% |
| FY2024 | 2024-12-31 | 0.71 | +36.5% |
| FY2023 | 2023-12-31 | 0.52 | +0.0% |
| FY2022 | 2022-12-31 | 0.52 | +842.9% |
| FY2021 | 2021-12-31 | (0.07) | — |
EPS (Diluted) vs competitors
How RYAN compares with its peers on the latest reported figures
- RYAN's LTM Jun 2026 EPS (Diluted) of $0.78 is the lowest of the 9 companies compared; the peer median is $9.2.
- Its year-over-year change of +559.5% is the highest of 9, against a peer median of +32.0%.
- Over three fiscal years its annual growth of -3.3% compares with a peer median of +6.1%.
| Company | Period | LTM | YoY | 3-year CAGR |
|---|---|---|---|---|
| LTM Jun 2026 | $58.47 | +49.2% | — | |
| LTM Jun 2026 | $12.79 | +32.1% | +45.1% | |
| LTM Jun 2026 | $11.76 | +104.9% | -9.1% | |
| LTM Sep 2026 | $11.07 | +31.9% | +6.1% | |
| LTM Sep 2026 | $7.32 | +6.6% | -3.7% | |
| LTM Sep 2026 | $7.1 | +53.0% | +34.8% | |
| LTM Jun 2026 | $5.91 | +18.2% | +13.7% | |
| LTM Sep 2026 | $2.37 | -23.8% | +4.0% | |
| LTM Jun 2026 | $0.78 | +559.5% | -3.3% | |
| Peer median (excluding RYAN) | $9.2 | +32.0% | +6.1% | |
Competitors are the stored peer set for RYAN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 1.43B | 1.73B | 2.08B | 2.52B | 3.05B |
| Cost of Revenue | 0 | 0 | 0 | 0 | 287.52M |
| Gross Profit | 1.43B | 1.73B | 2.08B | 2.52B | 2.76B |
| Gross Margin | 100.0% | 100.0% | 100.0% | 100.0% | 90.6% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 1.13B | 1.33B | 1.6B | 1.94B | 453.45M |
| Operating Expenses | 1.37B | 1.55B | 1.84B | 2.24B | 2.14B |
| Depreciation & Amortization | 112.68M | 109.29M | 115.84M | 167.63M | 287.52M |
| EBITDA | 253.6M | 393.31M | 473.27M | 598.63M | 803.08M |
| EBITDA Margin | 17.7% | 22.8% | 22.8% | 23.8% | 26.3% |
| Operating Income | 61.56M | 179.19M | 237.93M | 272.55M | 625.23M |
| Operating Margin | 4.3% | 10.4% | 11.5% | 10.8% | 20.5% |
| Interest Income | 0 | 0 | 0 | 0 | 56.54M |
| Interest Expense | 79.35M | 104.83M | 119.51M | 158.45M | 222.38M |
| Other Income / Expenses | 0 | 0 | 0 | 0 | (332.05M) |
| Income Before Tax | 61.56M | 179.19M | 237.93M | 272.55M | 293.18M |
| Pre-Tax Margin | 4.3% | 10.4% | 11.5% | 10.8% | 9.6% |
| Income Tax Expense | 4.93M | 15.94M | 43.45M | 42.64M | 79.03M |
| Net Income | 65.87M | 61.05M | 61.04M | 94.67M | 63.4M |
| Net Margin | 4.6% | 3.5% | 2.9% | 3.8% | 2.1% |
| EPS (Basic) | (0.07) | 0.56 | 0.57 | 0.78 | 0.50 |
| EPS (Diluted) | (0.07) | 0.52 | 0.52 | 0.71 | 0.47 |
| Weighted Avg Shares | 105.73M | 108.62M | 114.36M | 120.78M | 127.27M |
| Weighted Avg Shares (Diluted) | 105.73M | 265.75M | 125.75M | 274.84M | 278.51M |
Ryan Specialty Holdings, Inc.
NYSE:RYAN
Intrinsic Alpha fair value
Locked
Current Price
$48.38
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.